Leading Dermatology Contract Research Organization bioskin® Joins Medrio's Partner Program

NAPA, Calif. -- bioskin®, a leading dermatology CRO offering global clinical trial services, announces they have joined the Medrio partner program.  Using Medrio's eClinical Software as a Service (SaaS) suite, bioskin®is able to provide clients a user-friendly, efficient and cost-effective solution for data collection.  

"Our data managers are able to build the study themselves, without losing valuable time communicating with external programmers.  The advantage for the client is faster implementation of a study database," said Walter Wigger-Alberti, CEO of bioskin®.

bioskin®'s partnership with Medrio will help deliver the best possible experience for customers.

"We are thrilled to add bioskin® to Medrio's partner program," added Scott Weidley, Vice President of Sales and Marketing at Medrio. "Over the past year, we've worked closely with bioskin® and look forward to continuing our collaboration through our partnership."

About bioskin®
bioskin® is a full-service CRO specialized in dermatology and related indications. We offer strategic planning and regulatory support for global dermatological product development as well as all core operational services for management of Phase I-IV clinical trials and medical device trials. Founded in 1992, bioskin® is headquartered in Hamburg, Germany and Napa, California. For more information visit: www.bioskinCRO.com.

About Medrio, Inc. 
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies. Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information visit: www.medrio.com.

bioskin® will be attending the DIA 50th Annual Meeting (booth #2230) from June 16-18 as well as the BIO International Convention from June 23-26 in San Diego. To make an appointment please contact [email protected].

Contact Information:


Europe Office: 

US Office:

Betsy Hughes-Formella, PhD 

AJ Acker

+49 40 60689713

1 (707) 260-9109




Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.